Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis (original) (raw)
Müller-Ladner U, Gay RE, Gay S . Molecular biology of cartilage and bone destruction. Curr Opin Rheumatol 1998; 10: 212–219. ArticlePubMed Google Scholar
Bresnihan B . Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999; 26: 717–719. CASPubMed Google Scholar
Pap T et al. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2000; 2: 59–64. ArticleCASPubMed Google Scholar
Tak PP, Zvaifler NJ, Green DR, Firestein GS . Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000; 21: 78–82. ArticleCASPubMed Google Scholar
Oppenheimer-Marks N, Lipsky PE . Adhesion molecules in rheumatoid arthritis. Springer Semin Immunopathol 1998; 20: 95–114. ArticleCASPubMed Google Scholar
Konttinen YT et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 691–697. ArticleCASPubMedPubMed Central Google Scholar
van der Laan WH et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor. Arthritis Rheum 2000; 43: 1710–1718. ArticleCASPubMed Google Scholar
Keyszer G et al. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum 1998; 41: 1378–1387. ArticleCASPubMed Google Scholar
Pap T, Müller-Ladner U, Gay RE, Gay S . Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000; 2: 361–367. ArticleCASPubMedPubMed Central Google Scholar
Maciewicz RA, Wotton SF, Etherington DJ, Duance VC . Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett 1990; 269: 189–193. ArticleCASPubMed Google Scholar
Nguyen Q, Mort JS, Roughley PJ . Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B. Biochem J 1990; 266: 569–573. CASPubMedPubMed Central Google Scholar
Kane SE, Gottesman MM . The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990; 1: 127–136. CASPubMed Google Scholar
Iwata Y, Mort JS, Tateishi H, Lee ER . Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis. Arthritis Rheum 1997; 40: 499–509. ArticleCASPubMed Google Scholar
Trabandt A et al. Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/I mice and patients with rheumatoid arthritis. Matrix 1990; 10: 349–361. ArticleCASPubMed Google Scholar
Keyszer GM et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization. Arthritis Rheum 1995; 38: 976–984. ArticleCASPubMed Google Scholar
Dohchin A et al. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 2000; 89: 482–487. ArticleCASPubMed Google Scholar
Strojnik T, Zidanik B, Kos J, Lah TT . Cathepsins B and L are markers for clinically invasive types of meningiomas. Neurosurgery 2001; 48: 598–605. ArticleCASPubMed Google Scholar
Strojan P et al. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2000; 6: 1052–1062. CASPubMed Google Scholar
Soderstrom M et al. Cysteine proteinases in chondrosarcomas. Cysteine proteinases in chondrosarcomas. Matrix Biol 2001; 19: 717–725. ArticleCASPubMed Google Scholar
Putnam DA . Antisense strategies and therapeutic applications. Am J Health Syst Pharm 1996; 53: 151–160. CASPubMed Google Scholar
Sullivan SM . Development of ribozymes for gene therapy. J Invest Dermatol 1994; 103: 85S–89S. ArticleCASPubMed Google Scholar
Campbell TB, Sullenger BA . Alternative approaches for the application of ribozymes as gene therapies for retroviral infections. Adv Pharmacol 1995; 33: 143–178. ArticleCASPubMed Google Scholar
Müller-Ladner U et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607–1615. PubMedPubMed Central Google Scholar
Burstein H . Gene therapy for rheumatoid arthritis. Curr Opin Mol Ther 2001; 3: 362–374. CASPubMed Google Scholar
Evans CH et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996; 7: 1261–1280. ArticleCASPubMed Google Scholar
Gouze E et al. Gene therapy for rheumatoid arthritis. Expert Opin Biol Ther 2001; 1: 971–978. ArticleCASPubMed Google Scholar
Pap T, Gay RE, Müller-Ladner U, Gay S . Ex vivo gene transfer in the years to come. Arthritis Res 2002; 4: 10–12. ArticleCASPubMed Google Scholar
Perlman H et al. Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 2000; 164: 5227–5235. ArticleCASPubMed Google Scholar
van der Laan WH et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Therapy 2003; 10: 234–242. ArticleCASPubMed Google Scholar
Neumann E et al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Therapy 2002; 9: 1508–1519. ArticleCASPubMed Google Scholar
Kirschke H et al. Antisense RNA inhibition of cathespin L expression reduces tumorigenicity of malignant cells. Eur J Cancer 2000; 36: 787–795. ArticleCASPubMed Google Scholar
Krueger S, Kellner U, Buehling F, Roessner A . Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Cancer Gene Ther 2001; 8: 522–528. ArticleCASPubMed Google Scholar
Kitajima I et al. Ribozyme-based gene cleavage approach to chronic arthritis associated with human T cell leukemia virus type I: induction of apoptosis in synoviocytes by ablation of HTLV-I tax protein. Arthritis Rheum 1997; 40: 2118–2127. ArticleCASPubMed Google Scholar
Macejak DG et al. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 2000; 31: 769–776. ArticleCASPubMed Google Scholar
Macejak DG et al. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA. J Viral Hepat 2001; 8: 400–405. ArticleCASPubMed Google Scholar
Arnett FC et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324. ArticleCASPubMed Google Scholar
Gewirtz AM, Sokol DL, Ratajczak MZ . Nucleic acid therapeutics: state of the art and future prospectives. Blood 1998; 92: 712–736. CASPubMed Google Scholar
James HA, Gibson I . The therapeutic potential of ribozymes. Blood 1998; 91: 371–382. CASPubMed Google Scholar
Zuker M, Jacobson AB . Well-determined regions in RNA secondary structure predictions: analysis of small subunit ribosomal RNA. Nucleic Acids Res 1995; 23: 2791–2798. ArticleCASPubMedPubMed Central Google Scholar
Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP . Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. J Clin Invest 1998; 81: 1621–1629. Article Google Scholar
Neidhart M, Gay RE, Gay S . Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2000; 43: 1719–1728. ArticleCASPubMed Google Scholar